Specialist neuromodulation · UK
Neuromodulation, the right device for the right problem.
An umbrella guide to implanted neurostimulation in the UK - deep brain, spinal cord, dorsal root ganglion, sacral, vagus and peripheral nerve, plus intrathecal drug delivery. Chosen through a specialist MDT, trialled before it is permanent where possible, and programmed for life.
Why patients choose us
- 01
A specialist MDT, not a single opinion
Functional neurosurgery, pain medicine, urology or neurology - whichever team actually fits your problem, sitting round the same table.
- 02
A trial before the permanent implant
For SCS, DRG, PNS and sacral neuromodulation, a one to two-week percutaneous trial happens before you commit to a permanent device.
- 03
Independent, and free
We are paid by no centre, so the recommendation on device, target and team is impartial and costs you nothing.
Indicative pricing
What private neuromodulation costs in the UK.
Indicative ranges across our specialist UK centres. NHS funding applies for NICE-approved indications through referral to a specialist centre. Send the details and we quote firm figures.
In short
Spinal cord stimulation privately: £15,000–£28,000, trial before the permanent implant.
| Modality | Indicative range | Format | Stay / trial |
|---|---|---|---|
| Spinal cord stimulation (SCS) - trial + permanent | £15,000–£28,000 | 2 stages | Trial 1–2 wks |
| Dorsal root ganglion (DRG) stimulation | £18,000–£32,000 | 2 stages | Trial 1–2 wks |
| Deep brain stimulation (DBS) - bilateral | £25,000–£45,000 | Inpatient | 2–3 nights |
| Sacral neuromodulation (SNM) - trial + permanent | £14,000–£22,000 | 2 stages | Trial 2 wks |
| Vagus nerve stimulation (VNS) | £20,000–£35,000 | Day-case | Same day |
| Intrathecal baclofen (ITB) pump | £14,000–£20,000 | Half-day | Overnight |
| Peripheral / occipital nerve stimulation (PNS/ONS) | £12,000–£20,000 | 2 stages | Trial 1–2 wks |
| Specialist consultation + MDT review | £350–£600 | 45–60 min | 1–2 wks |
Prices vary by centre, by device manufacturer and generation, by whether the trial is billed separately, and by ITU or ward requirements after DBS. Rechargeable and MR-conditional systems typically sit at the higher end of the range.
The problem
The right team, the right target, the right device.
Neuromodulation is highly effective when it fits - and unhelpful when it does not. Choosing the modality, the target and the centre is the entire game.
-
Is stimulation actually right for me?
A specialist MDT with functional neurosurgery, pain and - where relevant - psychology, decides whether an implant is likely to help before you commit.
-
Will it work for my pain or symptom?
For SCS, DRG, PNS and SNM, a one to two-week trial phase tests the answer in the real world before any permanent device is placed.
-
Where should this actually be done?
DBS, complex SCS revisions and epilepsy neuromodulation belong in high-volume UK centres. We help route you accordingly.
The journey
From enquiry to programming - what happens, in order.
A concierge that stays with you through MDT, trial, permanent implant and the long tail of programming and battery life.
Phase 1 · Before your implant
Concierge, off-stage for you
Phase 2 · Trial and permanent
In-hospital, staged
Phase 3 · After
Programming, long-term
- 01
Before
You tell us what is going on
A short, confidential form. Diagnosis, previous treatments tried, imaging and clinic letters so far.
- 02
Before
We come back with a recommendation
Within one working day: the right modality (DBS, SCS, DRG, SNM, VNS, ITB), the right specialist centre and an indicative price. If neuromodulation is not the right step, we say so.
- 03
Before
MDT review and specialist assessment
A functional neurosurgeon, pain specialist, uro-neurologist or neurologist assesses you formally, with the MDT signing off.
- 04
Implant
Trial phase where applicable
For SCS, DRG, PNS and SNM, a percutaneous lead is placed under LA or sedation and connected to an external stimulator for one to two weeks.
- 05
Implant
Permanent implant
60 to 180 minutes per stage in a proper theatre. Leads placed, IPG tunnelled to abdomen, buttock or chest. Day-case or one night.
- 06
After
Programming and tuning
Post-implant sessions with the device rep and your specialist to program stimulation, followed by ongoing tuning over weeks to months.
- 07
After
Long-term follow-up and battery
Annual reviews, MRI planning where relevant, and IPG battery replacement every five to ten years depending on device and usage.
Typical end-to-end: 6–12 weeks from enquiry to permanent implant. Programming continues for months.
When it helps
When neuromodulation is the right step.
The core UK indications, plus the red flag that means the device team needs you the same day, not next week.
-
Parkinson’s, tremor, dystonia
Motor fluctuations, medication-refractory tremor or dystonia that a functional neurosurgery MDT considers for DBS.
-
Failed back surgery syndrome
Persistent leg and back pain after spinal surgery, where neuropathic components are dominant - a common SCS indication.
-
Complex regional pain syndrome
CRPS of a limb, especially foot or knee, where DRG stimulation targets a specific dermatome precisely.
-
Painful diabetic neuropathy
Refractory painful diabetic peripheral neuropathy where NICE-approved SCS is now an option after conservative care.
-
Overactive bladder, retention, faecal incontinence
Idiopathic or neurogenic bladder or bowel dysfunction that has not settled with conservative or medical therapy - for SNM or PTNS.
-
Refractory epilepsy
Focal or generalised epilepsy not controlled by medication or resection - assessed for VNS or, in specialist centres, DBS-ANT.
-
Severe spasticity
MS, cerebral palsy, spinal cord injury or post-stroke spasticity that oral baclofen cannot control - for an intrathecal baclofen pump.
-
Red flag: new neurological deficit
New weakness, sudden loss of bladder or bowel control, or fever with an implanted device is an emergency - A&E, not a clinic booking.
Modalities
One family of therapies, many devices.
What each modality actually is, where it is placed and which problem it fits - the honest version.
-
Deep brain stimulation (DBS)
STN, GPi, VIM or PPN targets for Parkinson’s, tremor, dystonia and selected OCD, Tourette’s and epilepsy - at Queen Square, Oxford, Bristol, Newcastle, Leeds, Sheffield.
-
Spinal cord stimulation (SCS)
Tonic, HF10, burst or DTM waveforms for FBSS, CRPS, refractory neuropathic pain, angina, PVD and painful diabetic neuropathy per NICE.
-
Dorsal root ganglion (DRG) stimulation
Leads at T10–S2 targeting a specific DRG for focal neuropathic pain - CRPS foot or knee, post-surgical peripheral neuropathy, inguinodynia.
-
Sacral neuromodulation (SNM)
InterStim or Axonics devices for overactive bladder, non-obstructive urinary retention and faecal incontinence, NICE-approved after conservative therapy fails.
-
Vagus nerve stimulation (VNS)
Left cervical vagus lead with pulse generator on the chest for refractory epilepsy as an adjunct; limited UK use in treatment-resistant depression.
-
Peripheral and occipital nerve stimulation
Occipital nerve stimulation for refractory chronic migraine and cluster headache; peripheral leads for CRPS, phantom limb pain and meralgia paraesthetica.
-
Intrathecal drug delivery (ITB, morphine)
Programmable pump delivering baclofen for severe spasticity, or morphine for refractory chronic pain, straight into the intrathecal space.
-
Non-invasive options
PTNS in clinic for OAB and faecal incontinence, TMS for depression and migraine, Cefaly for migraine, tDCS in research settings.
Our vetted UK network
A small panel of specialist centres, we picked them.
Functional neurosurgery, pain and uro-neurology teams at high-volume UK centres - Queen Square UCLH, Oxford, Bristol, Newcastle, Leeds and Sheffield among them. Introductions are made privately once we understand your case.
Selection criteria
How we choose every centre and team in our network.
-
Functional neurosurgery, pain, uro-neurology or neurology consultants - appropriate to your indication
-
Formal MDT review before any implant is offered
-
Trial phase for SCS, DRG, PNS and SNM before the permanent device
-
Centres with device programming clinics and long-term follow-up in place
Safety and outcomes
What to expect - honestly.
Outcomes in the right hands are strong - around 60–70 per cent motor improvement for Parkinson’s DBS, 50–70 per cent pain reduction for SCS, and 60–80 per cent symptom improvement for sacral neuromodulation. The risks are real and worth naming.
-
Infection is the main early risk
Roughly 2–5 per cent of implants become infected. Careful theatre technique and antibiotics reduce it, but explant may still be needed if it occurs.
-
Lead migration and fracture
Leads can move or fracture, especially in mobile areas. Anchoring technique and modern lead design lower the risk, but revision is sometimes needed.
-
IPG site discomfort
Some patients feel the pulse generator where it sits in the abdomen, buttock or chest. Position and pocket depth are planned to minimise this.
-
Battery life is finite
Non-rechargeable IPGs last five to seven years typically; rechargeable devices ten years or more. Replacement is a small day-case procedure.
-
MRI compatibility varies
Most modern systems are MR-conditional under specific protocols. Older devices, or non-MRI leads, restrict future scanning - planned around your future needs.
-
Stimulation is not always effective
Even after a positive trial, some patients get less benefit long term. Reprogramming, waveform change or, occasionally, explant is part of honest follow-up.
-
DBS-specific: haemorrhage and stroke
Intracerebral haemorrhage occurs in roughly 1–2 per cent of DBS procedures; stroke in under 1 per cent. Discussed in detail during consent.
-
VNS-specific: voice and swallowing
Hoarseness during stimulation is common early on; cough, throat sensation or, rarely, swallowing difficulty can occur. Usually settles or is programmed around.
-
Red flags
Fever, spreading redness at any incision, new weakness, sudden device-site pain or unexpected shocks after an implant need same-day medical attention.
Reading your operation note
Your operation note in four parts. Read the last one first.
Whichever modality was used, the note the specialist team sends you keeps to the same shape.
A quiet reminder
Programming language is technical and can read coldly - we translate it for you.
If you would like us to talk you through your device settings, MRI conditions or trial percentages before clinic, just ask.
- 01 Header
Indication and modality chosen
Why neuromodulation was offered - Parkinson’s, FBSS, CRPS, OAB, epilepsy, spasticity - and which modality (DBS, SCS, DRG, SNM, VNS, ITB) the MDT agreed on.
- 02 Technique
Target, leads and IPG
The anatomical target (STN, T10 DRG, S3 root, cervical vagus, intrathecal), how many leads were placed, and where the IPG was tunnelled.
- 03 Findings
Trial response and intra-op testing
For staged implants, the percentage pain reduction or functional improvement during trial. For DBS, intra-op testing thresholds and side-effect map.
- 04 Impression
Programming plan and follow-up
Read this first: initial programme settings, when programming clinic starts, MRI conditions for your device, and the follow-up schedule.
Recognised by major UK insurers
Insurer cover for neuromodulation varies by indication, by device and by whether NICE-approved criteria are met. NHS specialist-centre funding is the main route for DBS, complex SCS and epilepsy neuromodulation. We confirm cover before booking.
Frequently asked
Everything we get asked about neuromodulation.
Quick answers on candidacy, trial phases, cost, MRI compatibility, batteries and the honest risks.
-
What is neuromodulation?
Neuromodulation is the use of implanted electrical stimulation - or, less often, targeted intrathecal drug delivery - to change how the nervous system behaves. It is used for movement disorders, chronic pain, bladder and bowel dysfunction, epilepsy and severe spasticity.
-
How do I know if I am a candidate?
A specialist MDT reviews your diagnosis, previous treatments, imaging and, where appropriate, psychology assessment. For SCS, DRG, PNS and SNM a percutaneous trial phase confirms whether stimulation actually helps you before any permanent device is offered.
-
What is a trial phase and why is it done?
For most non-cranial neuromodulation, a temporary lead is placed under local anaesthetic or sedation and connected to an external stimulator for one to two weeks. If pain, urgency or symptoms improve by roughly 50 per cent or more, a permanent implant is offered.
-
How much does private neuromodulation cost in the UK?
Indicative ranges: SCS or DRG £15,000–£32,000; DBS £25,000–£45,000; sacral neuromodulation £14,000–£22,000; VNS £20,000–£35,000; intrathecal baclofen pump £14,000–£20,000. NHS funding is available for NICE-approved indications through specialist centres.
-
Can I have an MRI with a neuromodulation device?
Most modern devices are MR-conditional, meaning MRI is allowed under specific scanner and programming conditions. Older systems, some full-body DBS leads and certain lead positions can restrict MRI - planned around your likely future imaging needs before implant.
-
How long does the battery last?
Non-rechargeable IPGs typically last five to seven years; rechargeable devices ten years or longer. Battery replacement is a straightforward day-case procedure once depletion is detected at programming clinic.
-
What are the main risks?
Infection (2–5 per cent), lead migration or fracture, IPG-site discomfort, hardware failure, ineffective stimulation and eventual battery depletion. DBS carries a 1–2 per cent risk of intracerebral haemorrhage and under 1 per cent of stroke. VNS can cause voice and swallowing changes.
-
When should I contact the specialist team urgently?
Fever, spreading redness at any incision, new weakness, sudden device-site pain, unexpected shocks, or new bladder or bowel changes after a spinal or sacral implant should be assessed the same day - through your specialist team or A&E.
Related treatments
Looking for something else?
-
Movement disorder treatment
DBS, medication and MDT care for Parkinson’s, tremor and dystonia.
Learn more -
Neurogenic bladder & bowel
Sacral neuromodulation and conservative pathways for neurogenic dysfunction.
Learn more -
Microvascular decompression
Neurosurgical option for trigeminal neuralgia and hemifacial spasm.
Learn more -
Migraine & headache
Preventive, acute and neuromodulation pathways for chronic headache.
Learn more -
All tests & procedures
Every test and procedure we arrange.
Learn more